Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax
Background: Aortic valve stenosis (AS) is the most common valvular disease. Its surgical indication is undisputed in symptomatic severe AS, however, 30% of patients are at high surgical risk or inoperable. Transcatheter Valve Implantation (TAVI) is an alternative for this group of patients. Aim: To...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Lenguaje: | Spanish / Castilian |
| Publicado: |
Sociedad Médica de Santiago
2015
|
| Materias: | |
| Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015001200002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:scielo:S0034-98872015001200002 |
|---|---|
| record_format |
dspace |
| spelling |
oai:scielo:S0034-988720150012000022016-02-29Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del TóraxPineda,FernandoSarango,ByronSore,LoretoDeck,CarlosTurner,EduardoParra,VíctorBórquez,EmilianoBernal,SergioSilva,JorgeGonzÁlez,SoledadUriarte,Polentzi Aortic valve replacement Aortic valve Aortic valve stenosis Background: Aortic valve stenosis (AS) is the most common valvular disease. Its surgical indication is undisputed in symptomatic severe AS, however, 30% of patients are at high surgical risk or inoperable. Transcatheter Valve Implantation (TAVI) is an alternative for this group of patients. Aim: To describe the clinical outcomes of TAVI in a group of patients treated at the Instituto Nacional del Tórax, Santiago, Chile. Patients and Methods: Prospective study including all patients referred for TAVI due to their high surgical risk or being inoperable. All-cause mortality, secondary stroke, permanent pacemaker implantation, vascular complications, prosthetic and periprosthetic regurgitation, Karnosfky test and Functional Capacity (FC) were assessed as endpoints. Results: We evaluated 26 patients with a mean age of 82 years (74% women) in whom 27 procedures were done. The mean Society of Thoracic Surgeons score was 8.8%. Overall mortality at 30 days, one and two years was 11.1, 18.5 and 29.6% respectively. Karnofsky score increased significantly from 62.3% at baseline to 83.9; 88.6 and 88.8% at six months, one and two years, respectively. Prior to the procedure, FC was 3.1 ± 0.6, decreasing significantly to 1.2; 1.3 and 1 at six months, one and two years of follow up. Conclusions: TAVI is an effective alternative treatment for patients with severe symptomatic AS and high surgical risk.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.143 n.12 20152015-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015001200002es10.4067/S0034-98872015001200002 |
| institution |
Scielo Chile |
| collection |
Scielo Chile |
| language |
Spanish / Castilian |
| topic |
Aortic valve replacement Aortic valve Aortic valve stenosis |
| spellingShingle |
Aortic valve replacement Aortic valve Aortic valve stenosis Pineda,Fernando Sarango,Byron Sore,Loreto Deck,Carlos Turner,Eduardo Parra,Víctor Bórquez,Emiliano Bernal,Sergio Silva,Jorge GonzÁlez,Soledad Uriarte,Polentzi Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax |
| description |
Background: Aortic valve stenosis (AS) is the most common valvular disease. Its surgical indication is undisputed in symptomatic severe AS, however, 30% of patients are at high surgical risk or inoperable. Transcatheter Valve Implantation (TAVI) is an alternative for this group of patients. Aim: To describe the clinical outcomes of TAVI in a group of patients treated at the Instituto Nacional del Tórax, Santiago, Chile. Patients and Methods: Prospective study including all patients referred for TAVI due to their high surgical risk or being inoperable. All-cause mortality, secondary stroke, permanent pacemaker implantation, vascular complications, prosthetic and periprosthetic regurgitation, Karnosfky test and Functional Capacity (FC) were assessed as endpoints. Results: We evaluated 26 patients with a mean age of 82 years (74% women) in whom 27 procedures were done. The mean Society of Thoracic Surgeons score was 8.8%. Overall mortality at 30 days, one and two years was 11.1, 18.5 and 29.6% respectively. Karnofsky score increased significantly from 62.3% at baseline to 83.9; 88.6 and 88.8% at six months, one and two years, respectively. Prior to the procedure, FC was 3.1 ± 0.6, decreasing significantly to 1.2; 1.3 and 1 at six months, one and two years of follow up. Conclusions: TAVI is an effective alternative treatment for patients with severe symptomatic AS and high surgical risk. |
| author |
Pineda,Fernando Sarango,Byron Sore,Loreto Deck,Carlos Turner,Eduardo Parra,Víctor Bórquez,Emiliano Bernal,Sergio Silva,Jorge GonzÁlez,Soledad Uriarte,Polentzi |
| author_facet |
Pineda,Fernando Sarango,Byron Sore,Loreto Deck,Carlos Turner,Eduardo Parra,Víctor Bórquez,Emiliano Bernal,Sergio Silva,Jorge GonzÁlez,Soledad Uriarte,Polentzi |
| author_sort |
Pineda,Fernando |
| title |
Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax |
| title_short |
Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax |
| title_full |
Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax |
| title_fullStr |
Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax |
| title_full_unstemmed |
Experiencia inicial del implante percutáneo de válvula aórtica en el Instituto Nacional del Tórax |
| title_sort |
experiencia inicial del implante percutáneo de válvula aórtica en el instituto nacional del tórax |
| publisher |
Sociedad Médica de Santiago |
| publishDate |
2015 |
| url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015001200002 |
| work_keys_str_mv |
AT pinedafernando experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT sarangobyron experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT soreloreto experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT deckcarlos experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT turnereduardo experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT parravictor experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT borquezemiliano experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT bernalsergio experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT silvajorge experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT gonzalezsoledad experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax AT uriartepolentzi experienciainicialdelimplantepercutaneodevalvulaaorticaenelinstitutonacionaldeltorax |
| _version_ |
1718436854982770688 |